Estimasi nilai pasar wajar PT Bristol-Myer Squibb Indonesia Tbk. pada saat diakuisisi oleh Taisho Pharmaceutical Co., Ltd by ADLIANSYAH, Gusti Fahmi

“…The purpose of this research is to estimate the equity fair market value of PT Bristol-Myer Squibb Indonesia Tbk when acquired by Taisho Pharmaceutical Co.,Ltd using Discounted Cash Flow Method and Relative Valuation Method. …”

Automated Recognition of Chemical Molecule Images Based on an Improved TNT Model by Yanchi Li, Guanyu Chen, Xiang Li

Subjects: Get full text

Structure of the human marker of self 5-transmembrane receptor CD47 by Gustavo Fenalti, Nicolas Villanueva, Mark Griffith, Barbra Pagarigan, Sirish Kaushik Lakkaraju, Richard Y.-C. Huang, Nadia Ladygina, Alok Sharma, David Mikolon, Mahan Abbasian, Jeffrey Johnson, Haralambos Hadjivassiliou, Dan Zhu, Philip P. Chamberlain, Ho Cho, Kandasamy Hariharan

Get full text

P997: FEDRATINIB IS EFFECTIVE IN RUXOLITINIB-RESISTANT CELLS: CLINICAL AND PRECLINICAL CORRELATIONS by Danny Jeyaraju, Sheida Hayati, Ann Polonskaia, Andrew Browne, Alberto Risueño, Patrick Hagner, Vikas Gupta, Moshe Talpaz, Christopher Hernandez, Vincent Chia, Patrick Brown, Daniel Lopes De Menezes, Ross La Motte-Mohs, Rajasekhar Nvs Suragani, Anita Gandhi

Get full text

Structures of mouse and human GITR–GITRL complexes reveal unique TNF superfamily interactions by Feng Wang, Bryant Chau, Sean M. West, Christopher R. Kimberlin, Fei Cao, Flavio Schwarz, Barbara Aguilar, Minhua Han, Winse Morishige, Christine Bee, Gavin Dollinger, Arvind Rajpal, Pavel Strop

Get full text

Next generation automated traceless cell chromatography platform for GMP-compliant cell isolation and activation by Sabine Radisch, Mateusz P. Poltorak, Michaela Wagner, Vlad Cletiu, Christian Radisch, Irina Treise, Steffi Pann, Alexis Weigt, Sophie Artner, Stefan Dreher, Fabian Fechner, Bojana Borjan, Simon P. Fraessle, Manuel Effenberger, Eileen Benke, Gottfried Navratil, Norbert Hentschel, Dirk H. Busch, Thomas Schmidt, Christian Stemberger, Lothar Germeroth

Get full text

P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE-CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH-RISK SUBSETS AND PRELIMINARY GENE SIGNAT... by N. Martin, A. Xu, N. Stong, J. Rytlewski, O. Finney, T. Campbell, W. Pierceall, E. Flynt, E. Thompson, S. Kaiser

Get full text

Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment by Peter M. Szabo, Amir Vajdi, Namit Kumar, Michael Y. Tolstorukov, Benjamin J. Chen, Robin Edwards, Keith L. Ligon, Scott D. Chasalow, Kin-Hoe Chow, Aniket Shetty, Mohan Bolisetty, James L. Holloway, Ryan Golhar, Brian A. Kidd, Philip Ansumana Hull, Jeff Houser, Logan Vlach, Nathan O. Siemers, Saurabh Saha

Get full text

Application of Pharmacokinetic/Pharmacodynamic Modeling to Bridge Mouse Antitumor Efficacy and Monkey Toxicology Data for Determining the Therapeutic Index of an Interleukin-10 Fc... by Zheng Yang, James Loy, Brian Poirson, Yanshan Dai, Surendran Rajendran, Shihua Xu, Vanessa Spires, Murali Gururajan, Zheng Lin, Jaren Arbanas, Stephen Carl, Samantha Pace, Yun Wang, John Mehl, Krishna Vasudevan, Thomas Spires, Ruslan Novosiadly, Shodeinde Coker, Raymond Perez, Kelly Covello, Paul Morin, Robert Graziano, Miranda Broz, Lois Lehman-McKeeman

Get full text

P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND RE... by Julia Piasecki, Keyur Desai, Carolyn Courtney, Ethan Thompson, James Pratt, Noopur Raje, Krina Patel, Marc S. Raab, Mark Cook, Katy Simonsen, Mihaela Popa Mckiver, Shari Kaiser, Nathan Martin

Get full text

LP-182 Pharmacokinetics, selectivity profile, and exposure-response relationship for efficacy and safety in a phase 2 study of deucravacitinib, an oral, selective, allosteric TYK2... by Bindu Murthy, Qihong Zhao, Takafumi Ide, Manoj Chiney, Huynh Yen Thanh Bach, Vineet Goti, Coburn Hobar, Urvi Aras

Design and characterization of mouse IgG1 and IgG2a bispecific antibodies for use in syngeneic models by Feng Wang, Jordan C. Tsai, Jonathan H. Davis, Bryant Chau, Jia Dong, Sean M. West, Jason M. Hogan, Matthew L. Wheeler, Christine Bee, Winse Morishige, Thomas Cayton, Donata David-brown, Chengyue Zhang, Alexander Kozhich, Tim Sproul, Gavin Dollinger, Arvind Rajpal, Pavel Strop

Get full text

972 Platinum-based chemotherapy reverses human MDSC phenotype and suppressive activity on CD8+ T cells by Yueyun Ding, Tyler Simpson, Rupal Bhatt, Ana Lako, Christine Tauras, Zoe Bleicher, Timothy Consedine, Benjamin Chen, Sangeeth George, David Balli, Sharmila Chamling Rai, Ailem Schrand, Joe DeBettencourt, William J Geese, Noe Ramirez-Alejo

P865: BIOMARKER ANALYSIS TO SUPPORT DOSE OPTIMIZATION OF IBERDOMIDE AS MONOTHERAPY AND IN COMBINATION WITH STANDARD OF CARE TREATMENTS FOR MULTIPLE MYELOMA FROM A PHASE 1/2 TRIAL by M. Amatangelo, Y. Cheng, W. Pierceall, N. W. van de Donk, S. Lonial, M. Wang, J. Emerson, K. Hong, P. Maciag, T. Peluso, A. Gandhi, A. Thakurta

Get full text

P412: LOW EXPOSURE, EXTENDED DOSING MIMICKING CLINICAL EXPOSURES OF ORAL AZACITIDINE SYNERGIZES WITH VENETOCLAX IN PRECLINICAL AML MODELS by D. Jeyaraju, M. Alapa, A. Polonskaia, A. Risueno Perez, R. Hurren, X. Wang, M. Gronda, A. Ahsan, C. Wang, P. Subramanyam, J. Sriganesh, A. Anand, M. Bysani Reddy, K. Ghosh, C. Kyriakopoulos, N. Lailler, C. Hartl, D. Lopes de Menezes, A. Schimmer, P. Hagner, A. Gandhi, A. Thakurta

Get full text

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models by Katherine E. Lewis, Mark J. Selby, Gregg Masters, Jose Valle, Gennaro Dito, Wendy R. Curtis, Richard Garcia, Kathy A. Mink, Kimberly S. Waggie, Matthew S. Holdren, Joseph F. Grosso, Alan J. Korman, Maria Jure-Kunkel, Stacey R. Dillon

Get full text

Improved Titer in Late-Stage Mammalian Cell Culture Manufacturing by Re-Cloning by Qin He, Matthew S. Rehmann, Jun Tian, Jianlin Xu, Luzmary Sabino, Erik Vandermark, Ziev Basson, Iris Po, Kathleen Bierilo, Gabi Tremml, Giovanni Rizzi, Erik F. Langsdorf, Nan-Xin Qian, Michael C. Borys, Anurag Khetan, Zheng-Jian Li

Get full text

Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer by Nataly Manjarrez-Orduño, Laurence C. Menard, Selena Kansal, Paul Fischer, Bijal Kakrecha, Can Jiang, Mark Cunningham, Danielle Greenawalt, Vishal Patel, Minghui Yang, Ryan Golhar, Julie A. Carman, Sergey Lezhnin, Hongyue Dai, Paul S. Kayne, Suzanne J. Suchard, Steven H. Bernstein, Steven G. Nadler

Get full text

P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON by E. N. Oliva, C. Chen, S. N. Rahim, B. Seuro, A. Vasconcelos, L. Gaugler, B. Skikne, T. Prebet, H. Cameron, C. Beach, G. Thompson

Get full text

P809: BASELINE CHARACTERISTICS IDENTIFYING PATIENTS WITH MULTIPLE MYELOMA TREATED WITH IDECABTAGENE VICELEUCEL (IDE-CEL; BB2121) WHO ARE AT RISK FOR SEVERE/REFRACTORY INFLAMMATORY... by Afshin Mashadi-Hossein, Julie Rytlewski, MD Shamsuzzaman, Debashree Basudhar, Mandeep Takhar, Ana Kostic, Timothy B. Campbell, Salomon Manier, Yi Lin, Nathan Martin

Get full text